These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25592653)

  • 21. Effects of 4-pyridine aldoxime on nerve agent-inhibited acetylcholinesterase activity in guinea pigs.
    Shih TM; Skovira JW; McDonough JH
    Arch Toxicol; 2009 Dec; 83(12):1083-9. PubMed ID: 19763542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The oxime pro-2-PAM provides minimal protection against the CNS effects of the nerve agents sarin, cyclosarin, and VX in guinea pigs.
    Shih TM; Guarisco JA; Myers TM; Kan RK; McDonough JH
    Toxicol Mech Methods; 2011 Jan; 21(1):53-62. PubMed ID: 21117832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel bifunctional hybrid small molecule scavengers for mitigating nerve agents toxicity.
    Amitai G; Gez R; Raveh L; Bar-Ner N; Grauer E; Chapman S
    Chem Biol Interact; 2016 Nov; 259(Pt B):187-204. PubMed ID: 27129421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioscavenger is effective as a delayed therapeutic intervention following percutaneous VX poisoning in the guinea-pig.
    Mann TM; Price ME; Whitmore CL; Perrott RL; Laws TR; McColm RR; Emery ER; Tattersall JEH; Green AC; Rice H
    Toxicol Lett; 2018 Sep; 293():198-206. PubMed ID: 29183815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: implications for public protection.
    Munro N
    Environ Health Perspect; 1994 Jan; 102(1):18-38. PubMed ID: 9719666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of the oxime HI-6 on miosis induced by topical administration of sarin and VX in the rabbit eye].
    Macić I; Vojvodić V; Knezević D; Maksimović M
    Vojnosanit Pregl; 1990; 47(6):399-401. PubMed ID: 2075700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An unexpected plasma cholinesterase activity rebound after challenge with a high dose of the nerve agent VX.
    Dorandeu F; Foquin A; Briot R; Delacour C; Denis J; Alonso A; Froment MT; Renault F; Lallement G; Masson P
    Toxicology; 2008 Jun; 248(2-3):151-7. PubMed ID: 18450356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neurological effects of chemical and biological weapons].
    Inoue N
    Rinsho Shinkeigaku; 2003 Nov; 43(11):880-2. PubMed ID: 15152492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo microdialysis and electroencephalographic activity in freely moving guinea pigs exposed to organophosphorus nerve agents sarin and VX: analysis of acetylcholine and glutamate.
    O'Donnell JC; McDonough JH; Shih TM
    Arch Toxicol; 2011 Dec; 85(12):1607-16. PubMed ID: 21695469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute pulmonary toxicity following inhalation exposure to aerosolized VX in anesthetized rats.
    Peng X; Perkins MW; Simons J; Witriol AM; Rodriguez AM; Benjamin BM; Devorak J; Sciuto AM
    Inhal Toxicol; 2014 Jun; 26(7):371-9. PubMed ID: 24766293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production and characterization of antibodies directed against organophosphorus nerve agent VX.
    Grognet JM; Ardouin T; Istin M; Vandais A; Noel JP; Rima G; Satge J; Pradel C; Sentenac-Roumanou H; Lion C
    Arch Toxicol; 1993; 67(1):66-71. PubMed ID: 8452483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of whole-body VX vapor exposure on lethality in rats.
    Benton BJ; McGuire JM; Sommerville DR; Dabisch PA; Jakubowski EM; Matson KL; Mioduszewski RJ; Thomson SA; Crouse CL
    Inhal Toxicol; 2006 Dec; 18(14):1091-9. PubMed ID: 17050346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioanalytical verification of V-type nerve agent exposure: simultaneous detection of phosphonylated tyrosines and cysteine-containing disulfide-adducts derived from human albumin.
    Kranawetvogl A; Küppers J; Siegert M; Gütschow M; Worek F; Thiermann H; Elsinghorst PW; John H
    Anal Bioanal Chem; 2018 Feb; 410(5):1463-1474. PubMed ID: 29322229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel brain-penetrating oximes for reactivation of cholinesterase inhibited by sarin and VX surrogates.
    Chambers JE; Meek EC; Chambers HW
    Ann N Y Acad Sci; 2016 Jun; 1374(1):52-8. PubMed ID: 27153507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural Detoxification Capacity to Inactivate Nerve Agents Sarin and VX in the Rat Blood.
    Bajgar J; Cabal J; Kassa J; Pavlík M
    Acta Medica (Hradec Kralove); 2015; 58(4):128-30. PubMed ID: 26960825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of aqueous dilution on the absorption of the nerve agent VX through skin in vitro.
    Dalton C; Graham S; Jenner J
    Toxicol In Vitro; 2018 Dec; 53():121-125. PubMed ID: 30099087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of human serum albumin by the nerve agent VX: microbore liquid chromatography/electrospray ionization high-resolution time-of-flight tandem mass spectrometry method for detection of phosphonylated tyrosine and novel cysteine containing disulfide adducts.
    Kranawetvogl A; Worek F; Thiermann H; John H
    Rapid Commun Mass Spectrom; 2016 Oct; 30(19):2191-200. PubMed ID: 27490696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxotremorine-induced hypothermia as a method for evaluating long-term neuronal changes following poisoning by cholinesterase inhibitors in rats.
    Grauer E; Levy A
    Toxicology; 2007 Dec; 242(1-3):1-6. PubMed ID: 17931764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds: pig versus minipig acetylcholinesterase.
    Worek F; Aurbek N; Wetherell J; Pearce P; Mann T; Thiermann H
    Toxicology; 2008 Feb; 244(1):35-41. PubMed ID: 18054823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the hydrolytic stability of S-(N,N-diethylaminoethyl) isobutyl methylphosphonothiolate with VX in dilute solution.
    Crenshaw MD; Hayes TL; Miller TL; Shannon CM
    J Appl Toxicol; 2001 Dec; 21 Suppl 1():S3-6. PubMed ID: 11920912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.